While in the discovery cohort the NAFL and NASH patients had similar circulating AST and ALT, in the validation cohort these liver injury markers and liver fat content evaluated by magnetic resonance imaging and Folch method were increased in NASH vs. NAFL (p < 0.05). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.